Sign In
Buy ABMT
Advanced BioMedical Technologies Stock Insider Power
Based on the 38 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 2.51M and sold 0 ABMT shares in the last 38 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
0 |
| ● Buy | 2.51M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Oct 26, 2021 Buy |
Advanced Biomedical Technologies Inc. Director |
100 000 Value: $7K |
||
|
Oct 26, 2021 Buy |
Advanced Biomedical Technologies Inc. Director |
200 000 Value: $14.6K |
||
|
Oct 26, 2021 Buy |
Advanced Biomedical Technologies Inc. Director |
200 000 Value: $14.6K |
||
|
Oct 26, 2021 Buy |
Advanced Biomedical Technologies Inc. Director |
100 000 Value: $7K |
||
|
Sep 23, 2021 Buy |
Advanced Biomedical Technologies Inc. Chief Medical Officer |
80 000 Value: $9K |
||
|
Sep 23, 2021 Buy |
Advanced Biomedical Technologies Inc. Chief Medical Officer |
80 000 Value: $9K |
||
|
Oct 30, 2020 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $23.0K |
||
|
Oct 30, 2020 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $23.0K |
||
|
Mar 09, 2020 Buy |
Advanced Biomedical Technologies Inc. Chief Medical Officer |
0 Value: $0 |
||
|
Mar 09, 2020 Buy |
Advanced Biomedical Technologies Inc. Chief Medical Officer |
0 Value: $0 |
||
|
Oct 30, 2019 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $15.3K |
||
|
Oct 30, 2019 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $15.3K |
||
|
Oct 30, 2019 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $9K |
||
|
Oct 30, 2019 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $6K |
||
|
Oct 30, 2019 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $6K |
||
|
Oct 30, 2019 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $9K |
||
|
Oct 23, 2018 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $31.7K |
||
|
Oct 23, 2018 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $21.1K |
||
|
Oct 23, 2018 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $21.1K |
||
|
Oct 23, 2018 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $31.7K |
||
|
Apr 28, 2017 Buy |
Advanced Biomedical Technologies Inc. President |
100 000 Value: $15.0K |
||
|
Apr 28, 2017 Buy |
Advanced Biomedical Technologies Inc. CFO |
150 000 Value: $22.5K |
||
|
Oct 31, 2016 Buy |
Advanced Biomedical Technologies Inc. President |
0 Value: $0 |
||
|
Oct 31, 2016 Buy |
Advanced Biomedical Technologies Inc. President |
0 Value: $0 |
||
|
Mar 08, 2012 Buy |
Lynch John Thomas Jr Advisor |
0 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
